Home
Don't miss out
Subscribe to STAT+ today, for the best life sciences journalism in the industry
for the latest news and insights in the world of life sciences, medicine, biotech, and pharma
at exclusive live and virtual events hosted by STAT
with subscriber-only newsletters delivered to your inbox daily
with our premium data tools
for the latest news and insights in the world of life sciences, medicine, biotech, and pharma
at exclusive live and virtual events hosted by STAT
with subscriber-only newsletters delivered to your inbox daily
with our premium data tools
for the latest news and insights in the world of life sciences, medicine, biotech, and pharma
at exclusive live and virtual events hosted by STAT
with subscriber-only newsletters delivered to your inbox daily
with our premium data tools
for the latest news and insights in the world of life sciences, medicine, biotech, and pharma
at exclusive live and virtual events hosted by STAT
with subscriber-only newsletters delivered to your inbox daily
with our premium data tools
By Annalisa Merelli Dec. 5, 2023
Understand how science, health policy, and medicine shape the world everyday. Sign up for our Morning Rounds newsletter here.
Buongiorno, Nalis here! A question for you to consider: Is it fair to let the Sacklers off the hook from facing future justice, if that is the best guarantee of compensation to victims of the opioid epidemic? Don’t worry if you’re not sure; the Supreme Court doesn’t seem to know either. Another hard question: mRNA vaccines for the seasonal flu — yes, or no? Keep reading to find out more, and send us your thoughts.
advertisement
The Supreme Court heard arguments on Monday about whether the Sackler family, the owner of Purdue Pharma, could be shielded from future civil lawsuits under the terms of their bankruptcy deal. As part of the deal, the Sacklers would pay up to $6 billion toward compensating people affected by the opioid crisis and, in exchange, would not face personal liability in the future.
Get unlimited access to award-winning journalism and exclusive events.
General Assignment Reporter
Annalisa (Nalis) Merelli is a general assignment reporter at STAT.
global health
Health Disparities
health tech
insurance
legal
patients
Pharmaceuticals
public health
research
STAT encourages you to share your voice. We welcome your commentary, criticism, and expertise on our subscriber-only platform, STAT+ Connect
To submit a correction request, please visit our Contact Us page.
advertisement
Reporting from the frontiers of health and medicine
Company
Account
More
Become a STAT+ subscriber today!
Become a STAT+ subscriber today!
Unlimited access to essential biotech, medicine, and life sciences journalism
Become a STAT+ subscriber today!
Become a STAT+ subscriber today!
Your go-to source for the latest news and insights on biopharma and the life sciences
Become a STAT+ subscriber today!
Become a STAT+ subscriber today!
Unlimited access to essential biotech, medicine, and life sciences journalism
Become a STAT+ subscriber today!
Become a STAT+ subscriber today!
Your go-to source for the latest news and insights on biopharma and the life sciences
